Pharmacology & ToxicologybioRxivPreprint
Discovery of a Novel, Selective and Short-Acting Skeletal Myosin II Inhibitor
L. Radnai, M. Surman, M. Hafenbreidel…·C. A. Miller
This study discovers and characterizes skeletostatins, selective skeletal myosin II inhibitors with improved properties for research and drug development.
DOI 10.1101/2020.07.28.225383